11,264
Total Claims
$1.3M
Drug Cost
921
Beneficiaries
$1,414
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-92%
Opioid rate vs peers
0.2% vs 2.2% avg
0%
Cost per patient vs peers
$1,414 vs $1,411 avg
Opioid Prescribing
0.2%
Opioid Rate
21
Opioid Claims
$200
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
89% generic
Brand: 1,187 claims · $1.1M
Generic: 9,965 claims · $234K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 220 | $276K |
| Semaglutide | 84 | $162K |
| Empagliflozin | 81 | $135K |
| Dulaglutide | 54 | $123K |
| Evolocumab | 64 | $71K |
| Sitagliptin Phosphate | 49 | $44K |
| Rivaroxaban | 25 | $40K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $24K |
| Rosuvastatin Calcium | 991 | $24K |
| Dapagliflozin Propanediol | 21 | $18K |
| Atorvastatin Calcium | 849 | $16K |
| Insulin Aspart | 11 | $14K |
| Losartan Potassium | 662 | $13K |
| Pitavastatin Calcium | 23 | $12K |
| Umeclidinium Brm/Vilanterol Tr | 15 | $11K |
Prescribing Profile
Patient Profile
77
Avg Age
52%
Female
1.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data